BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26365116)

  • 1. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.
    Lan XP; Chen YG; Wang Z; Yuan CW; Wang GG; Lu GL; Mao SW; Jin XB; Xia QH
    J Zhejiang Univ Sci B; 2015 Sep; 16(9):743-56. PubMed ID: 26365116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
    Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.
    Wang ZX; Cao JX; Liu ZP; Cui YX; Li CY; Li D; Zhang XY; Liu JL; Li JL
    World J Gastroenterol; 2014 Jan; 20(4):1095-106. PubMed ID: 24574784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis.
    Yuan X; Zhang AZ; Ren YL; Wang XL; Jiang CH; Yang L; Liu CX; Liang WH; Pang LJ; Gu WY; Li F; Hu JM
    Medicine (Baltimore); 2021 Apr; 100(13):e24519. PubMed ID: 33787569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis.
    Wang ZX; Cao JX; Wang M; Li D; Cui YX; Zhang XY; Liu JL; Li JL
    Cytotherapy; 2014 Jul; 16(7):934-45. PubMed ID: 24794183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
    Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
    Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Sun YP; Wang YZ; Liu SY; Yu HS; Li CW; Zeng XT; Chen L; Yao XS; Feng JH
    J Immunol Res; 2018; 2018():9081938. PubMed ID: 30648123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.
    Zhao X; Ji CY; Liu GQ; Ma DX; Ding HF; Xu M; Xing J
    Int J Clin Exp Pathol; 2015; 8(10):13146-55. PubMed ID: 26722513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery.
    Li H; Wang C; Yu J; Cao S; Wei F; Zhang W; Han Y; Ren XB
    Cytotherapy; 2009; 11(8):1076-83. PubMed ID: 19929470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
    Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
    Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.
    Xiao Z; Wang CQ; Feng JH; Zhou MH; Wang YZ; Li NN; Sun YP; Liu SY; Yao XS; Li CW; Ma B; Ding J; Chen L
    Cytotherapy; 2019 Feb; 21(2):125-147. PubMed ID: 30554868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
    Wang S; Wang Z
    Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
    Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
    Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
    He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
    Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.
    Chen R; Deng X; Wu H; Peng P; Wen B; Li F; Li F
    Int Immunopharmacol; 2014 Oct; 22(2):451-64. PubMed ID: 25073120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.